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Abstract
The effectiveness of an aqueous extract of Caryocar brasiliense (Caryocaraceae) Camb pulp, popularly known in
Brazil as pequi, against clastogenicity induced by cyclophosphamide and bleomycin was evaluated using an in vivo
mouse bone marrow cell micronuclei test, an in vitro Chinese hamster ovary cell (CHO-K1) chromosome aberration
test and an in vitro antioxidant assay based on the oxidative damage to 2-deoxy-D-ribose (2-DR) induced by hydroxyl
radicals (•OH) generated by the reaction between ascorbic acid and (Fe III)-EDTA. In mouse bone marrow cells the
extract showed a protective effect against micronuclei induced by cyclophosphamide and bleomycin but did not inter-
fere with polychromatic bone marrow erythrocyte proliferation, except when the mice had been treated with the high-
est dose of cyclophosphamide. When CHO-K1 cells were pretreated by adding 0.01, 0.05 or 0.1 mL of extract per mL
of cell culture medium 24 or 48 h before bleomycin or cyclophosphamide there was a protective effect against chro-
mosome breaks and a significant decrease in the mitotic index (a measure of cytotoxicity) of the CHO-K1 cells. The
extract also had a protective effect against oxidative hydroxyl radical damage to 2-DR. This study suggests that C.
brasiliense pulp aqueous extract has anticlastogenic potential, possibly due to its antioxidative properties.
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Introduction
Medicinal plants often represent the only therapeutic
resource for many communities and ethnic groups. In the
Brazilian savannah (the cerrado), Caryocar brasiliense
Camb., popularly known as pequi, is a common tree fre-
quently used in folk medicine to treat many types of ail-
ment, such as influenza, asthma and other respiratory
diseases. The pulp of the fruit of this tree is often used in the
regional cooking in typical dishes such as “rice with pequi”
and contains many compounds with antioxidant properties
(Facioli and Gonçalves, 1998; Azevedo-Meleiro and Ro-
drigues-Amaya, 2004)
Due to the high biodiversity of tropical and sub-
tropical areas Latin America has many plant foods rich in
carotenes. However, particularly in Brazil, there is a serious
threat that carotenoid-rich indigenous species may be sup-
planted by introduced crops with a lower carotenoid con-
tent and disappear (Rodrigues-Amaya, 1999). Natural
antioxidant compounds in the human diet may prevent the
genetic effects of mutagens and carcinogens and many
studies have shown that an increased intake of fruits or veg-
etables rich in antioxidants decreases the level of oxidative
DNA damage (Duthie et al. 1996; Collins et al. 2001;
Dusinská et al. 2003). Extracts of the plant Toxicodendron
quercifolium (poison-ivy, eastern poison-oak) and the
mushroom Agaricus blazei (the Brazilian sun-mushroom)
have shown antigenotoxic activity when examined using
the in vivo mouse bone marrow micronucleus assay and the
in vitro Chinese hamster ovary cell (CHO-K1) chromo-
some aberration assay (Mersch-Sundermann et al. 2004;
Guterres et al. 2005; Bellini et al. 2006). Edenharder et al.
(2002) used various test-systems for the evaluation of
genotoxicity to demonstrate the protective effects of plant
beverages, fruits, vegetables and spices against genotoxi-
city induced by 2-acetylaminofluorene or 2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine and Edenharder et
al. (2003) reported that homogenates of spinach, artichoke,
peaches and black grapes reduced micronuclei (MN) induc-
tion in mouse bone marrow treated with benzo[a]pyrene.
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Many studies with Brazilian plants used in folk medi-
cine have shown antimutagenic properties due to a range of
substances that act as antioxidants. Nascimento et al.
(2006) reported that leaf extracts of Turnera ulmifolia, used
in Brazilian folk medicine for their anti-inflammatory ac-
tivity, reduce spontaneous lipid peroxidation in rat brain
homogenates as measured using the thiobarbituric acid re-
active substrates (TBARS – method, Janero 1990).
Delmanto et al., (2001) demonstrated that the edible mush-
room A. blazei, consumed as a food or tea, has anti-
clastogenic activity against in vivo clastogenicity induced
by cyclophosphamide. Nogueira et al. (2006) reported that
the flower extract of Melampodium divaricatum (known in
Brazil as the false-Calendula, or false-marigold) is used in
Brazil as an anti-inflammatory agent and possess chemo-
preventive properties when tested in different strains of
Salmonella typhimurium. Bleomycin sulfate is an glyco-
peptide antibiotic used in cancer chemotherapy and has
been shown to be a potent radiomimetic antibiotic which
induces micronuclei in humans, rats and mice through the
induction of oxidative DNA damage (Erexson et al., 1995).
The active mechanism of bleomycin has been related to the
activation of molecular oxygen in the presence of ferrous
iron, producing oxygen radicals such as superoxide anions
which are toxic and mutagenic in a variety of in vitro and in
vivo test systems (Sausville et al. 1978; Albertini and
Gurnier-Suillerot 1984; Sikic 1986). Cyclophosphamide is
an alkylating agent used to treat a wide range of neoplastic
diseases and also as an immunosuppressive agent prior to
organ transplantation (Anderson et al. 1995). Hepatic
mixed function oxidases activate cyclophosphamide, the
major anti-neoplastic metabolite of cyclophosphamide
degradation being phospharamide mustard which binds to
DNA forming labile covalent DNA adducts and cross-links
(Anderson et al. 1995). Cyclophosphamide has been
widely used as a positive control in the single-dose mouse
micronuclei assay because it induces a variety of changes in
genetic material (IARC 1981; Krishna et al. 1987).
During the study described in this paper we assessed
the anticlastogenic potential of C. brasiliense using the two
known clastogens bleomycin and cyclophosphamide and
the in vivo mouse bone marrow micronucleus assay and the
in vitro Chinese hamster ovary cell chromosome aberration
assay. We also assessed antioxidant properties using the
degradation of 2-deoxyribose in the Fenton reaction assay.
Material and Methods
Materials
Fresh Caryocar brasiliense Camb (Caryocaraceae)
fruits was purchased from a local market in January/
Febuary Brasília and aqueous extracts obtained by extract-
ing 100 g (wet weight) of the pulp in 1000 mL of distilled
water using Soxhlet extraction for 10 h under an argon at-
mosphere. After extraction the aqueous extract (henceforth
called simply ’the extract’) was immediately frozen at
-85 °C and stored until needed. Bleomycin (Chemical Ab-
stracts Service (CAS) registry number 011056-06-7) was
obtained as Bleoxane sulfate (Bristol-Myers, USA) and
cyclophosphamide (CAS 6055-19-2) as Genuxal (ASTA
Medica Laboratory, Brazil). This project was approved by
the Animal Ethics Committee of Institute of Biological Sci-
ences of the University of Brasilia.
Swiss mouse micronucleus test
Swiss albino mice of both sexes (60 days old and
weighing 30 ± 2 g) were obtained from the Central Animal
Facility of the University of Brasilia and randomly allo-
cated to groups M1 to M10 as shown in Table 1, each group
consisting of eight mice. Extract was administered to the
mice orally, either alone or in combination with single
intraperitoneal injections of bleomycin diluted in NaCl
0.9% or aqueous cyclophosphamide, see Table 1 for dos-
age. A control group (M1) was given water in place of ex-
tract and no clastogens were administered. The animals
were sacrificed by cervical dislocation and slides of bone
marrow cells were prepared according to a standard method
(Schmid, 1975). The frequency of micronuclei (MN) in
polychromatic erythrocytes (PCE) and the ratio of poly-
chromatic erythrocytes to total erythrocytes (%PCE) were
estimated by scoring 1000 PCE per animal. Results were
analyzed using the Mann-Whitney U test with α = 0.05.
The 2-deoxyribose degradation assay
The formation of hydroxyl radicals (•OH) by Fenton
reagents was quantified based on the oxidative degradation
of 2-deoxyribose (2-DR) and the quantification of its deg-
radation product (malonaldehyde) by condensation with
2-thiobarbituric acid – TBARS method (Janero, 1990). The
typical reaction was started by adding Fe(II) at a final con-
centration of 6 μM to a 0.5 mL final volume of 20 mM
phosphate buffer, 5 mM of 2-deoxyribose, Cu(II) (5 μM)
(pH = 7.2) and 100 μM H2O2 with and without 10 μM of
ascorbate as an iron chelator. Reactions were carried out for
10 min at 25 °C ± 1 °C and were stopped by adding of
0.5 mL of 50 mM NaOH containing 4% (w/v) phosphoric
acid. After boiling for 15 min, the absorbance of the solu-
tion containing the 2-DR oxidation products was measured
at 532 nm using an Hitachi U-2001 spectrophotometer. As-
says were conducted by adding 10, 20, 30, 40 50, 100 or
200 μL of extract to the mixture described above (without
ascorbate), pre-incubating for 30 min at 25 °C ± 1 °C and
then adding 100 μM ascorbate, incubating for 12 min and
stopping the reaction and measuring the absorbance as de-
scribed above. Spectra of the extract complexed with Fe(II)
or Fe(III) were obtained by pre-incubating the complexes
in the phosphate buffer described above for one hour and
measuring the absorbance at 532 nm in the absence of iron
against blanks of buffer and buffer containing the same
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concentration of extract. (Gutteridge, 1981; Halliwell et al.,
1987).
Chinese hamster ovary cell chromosome aberration
assay
Chinese hamster ovary cells strain K1 (CHO-K1)
were seeded in petri plates containing 10 mL of fresh com-
plete HAM-F12 medium (Gibco) containing 10% (v/v) fe-
tal calf serum (Gibco) and grown to 70% confluence before
being subjected to the treatments listed in Table 2 as groups
H1 to H9. A control group (H1) was mounted without ex-
tract or added clastogens. [See notes above.] Colchicine
(Sigma) was added during the last 2 h of incubation and all
the experiments were duplicated. Cultures were harvested
and by incubating at 37 °C for 10 min in hypotonic 0.075 M
KCl and then fixed in methanol/acetic acid (3:1 v/v). Slides
were stained for 10 min with 10% (v/v) Giemsa. One hun-
dred metaphases were analyzed for structural chromosome
aberrations (Savage, 1976) and the results were statistically
evaluated using the Mann-Whitney U test (α = 0.05).
Results
The in vivo micronucleus test showed that when ad-
ministered orally the extract (group M2) resulted in no sta-
tistically significant (p = 0.9369) increase in the number of
micronuclei compared with the M1 water control group, in-
dicating that the extract produced no clastogenic effect in
respect to micronuclei frequency (Table 1).
There was also no statistically significant difference
(p = 0.1) in the number of mouse polychromatic erythro-
cytes as a percentage of the total number of erythrocytes
(the proliferation index) between the M1 and the M2
groups (Table1) but the proliferation index decreased in
groups treated with extract plus 100 mg kg-1 bw bleomycin
(group M6, compared to groups M2 and M5) and extract
plus cyclophosphamide 66 mg kg-1 bw (group M10), indi-
cating a cytotoxic effect on bone marrow cells (Table 1).
As expected, the groups administered clastogens
without extract showed statistically significant increases in
micronucleus frequency when compared to the M1 group
and hence clastogenic effects (bleomycin: M3, p = 0.0001;
M5, p = 0.0093. cyclophosphamide: M7, p = 0.0001; M9,
p = 0.009.) and there was a marked increase in the number
of micronuclei in group M5 cells, treated with
100 mg kg-1bw bleomycin, as compared to group M3
treated with 50 mg kg-1bw bleomycin (Table 1).
For the groups administered extract followed by bleo-
mycin (groups M4 and M6) there was a significant decrease
in the micronucleus frequency compared to their respective
bleomycin-only controls (p = 0.009 for M4 compared to
M3; p = 0.0001 compared to M2 and M5), indicating that
the extract was anticlastogenic against bleomycin-induced
chromosome damage (Table 1). The M8 group adminis-
tered extract followed by 33 mg kg-1 cyclophosphamide
showed a statistically significant decrease (p = 0.009) in the
micronuclei frequency compared to the M7 control group.
However, the extract showed no statistically significant
protective effect (p = 0.0007) for the M10 group, adminis-
tered extract plus 66 mg kg-1 bw cyclophosphamide, com-
pared to the M9 matching cyclophosphamide control group
(Table 1). The micronucleus frequency induced by cyclo-
phosphamide in the M8 and M10 groups pre-treated with
extract remained high, while the proliferation index was
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Table 1 - The number of polychromatic erythrocytes as a percentage of the total number of erythrocytes (the proliferation index) and the mean number of
micronuclei in polychromatic and normochromatic erythrocytes of Swiss albino mice of both sexes treated orally with 0.03 mL of Caryocar brasiliense
(pequi) aqueous extract, equivalent to 1 mL kg-1 body weight (bw), alone or with a single intraperitoneal bleomycin or cyclophosphamide injection
administered 20 h before sacrifice for bleomycin and 24 h before sacrifice for cyclophosphamide. Each group contained eight mice. Significant









M1 Control (distilled water) 43.6 1.3 ± 0.3 1.3 ± 0.2
M2 Extract1, 0.03 mL orally for 10 days 51.4 1.4 ± 0.4 2.1 ± 0.5
M3 Bleomycin, 50 mg kg-1 bw 20 h before sacrifice 61.2 3.4 ± 0.6* 1.1 ± 0.3
M4 Extract as for M2 then bleomycin as in M3 53.5 1.7 ± 0.3† 0.4 ± 0.2
M5 Bleomycin, 100 mg kg-1 bw. 20 h before sacrifice 55.2 9.0 ± 4.6* 3.0 ± 1.3
M6 Extract as for M2 then bleomycin as in M5 38.3– 3.7 ± 3.2‡ 2.1 ± 0.8
M7 Cyclophosphamide 33 mg kg-1 bw 24 h before sacrifice 28.5* 28.4 ± 13.5* 4.6 ± 2.2
M8 Extract as for M2 then cyclophosphamide as in M7 38.7 18.2 ± 9.1# 4.4 ± 3.6
M9 Cyclophosphamide 66 mg kg-1 bw 24 h before sacrifice 25.1* 54.7 ± 27.4* 5.8 ± 4.1
M10 Extract as for M2 then cyclophosphamide as in M9 16.7 39.7 ± 21.4 3.5 ± 3.0
1Ratio of polychromatic erythrocytes to total erythrocytes. *significant at p < 0.05 compared to group M1. †significant at p < 0.05 compared to group M3.
‡significant at p < 0.05 compared to groups M2 and M5. #significant at p < 0.05 compared to group M7.
lower for both these groups than for the M1 water controls
(Table 1).
In the in vitro Chinese hamster cell (CHO) experi-
ments, there was also no evidence of chromosome aberra-
tions indicative of clastogenicity in the H2, H3, H4 and H5
groups treated with extract as compared to the H1 control
(Table 2) and the mitotic index of groups H2 to H5 was sig-
nificantly lower (p < 0.05) than that of the H1 control, indi-
cating that the extract possessed antiproliferative activity
(Table 2).
Our results indicate that bleomycin and cyclophos-
phamide were effective as positive DNA damage controls
for the CHO-K1 method. The H7 group treated with extract
followed by bleomycin showed a significantly lower total
number of chromosome aberrations as compared to the H6
group treated with bleomycin only and, similarly, the H9
group treated with extract followed by cyclophosphamide
showed a significantly lower total number of chromosome
aberrations compared to the H8 group treated with cyclo-
phosphamide only (Table 2). The mitotic index of the cells
in groups H2 to H9 were all significantly lower than the H1
control (Table 2)
We also found that the extract inhibited the Fenton re-
action, decreased the formation of hydroxyl radicals and re-
duced the oxidative degradation of 2-DR (Figure 1),
probably by removing Fe(III) from EDTA by the formation
of a complex with iron which is then unavailable for partici-
pation in the Fenton reaction.
Discussion
The C. brasiliense pulp was not analyzed by us but
the main antioxidant, carotenoid and mineral composition
of C. brasiliense has been investigated qualitatively and
quantitatively using high performance liquid chromatogra-
phy (Azevedo-Meleiro and Rodriguez-Amaya 2004) and
the fat and vitamin composition described using gas chro-
matography (Facioli and Gonçalves 1998), this data being
summarized Table 3.
We found that C. brasiliense aqueous extract showed
anticlastogenic activity and was able to inhibit bleomycin-
induced DNA damage in mice (Table 1). Bleomycin causes
various types of oxidative DNA lesions by generating reac-
tive oxygen species (ROS) (Povirk, 1996), which have
been shown to cause DNA damage, gene mutation, micro-
nuclei formation and chromosome aberrations (Imlay and
Linn, 1988; Gutteridge, 1993; Schiffl et al 1997; Cooke et
al., 2003).
We found that the extract decreased the formation of
hydroxyl radicals and reduced the oxidative degradation of
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Table 2 - Number of chromosome aberrations and percentage mitotic index (MI) recorded in Chinese hamster ovary cells (CHO-K1) subjected to differ-
ent in vitro treatments and treatment times with Caryocar brasiliense (pequi) aqueous extract, with or without the clastogens cyclophosphamide and
bleomycin. Aliquots of the extracts were sterilized using a Millipore 0.2 mm nitrocellulose membrane before addition to the medium. Significant differ-
ences by the Mann-Whitney U test are shown for the total aberrations and the percentage MI. Aberration key: F = fragment; D = dicentric; B’ = chromatid
break; B” = chromosome break; CB = centromere break; and G’ = chromatid gap.
Chromosome aberrations
Group Treatments F D B’ B” CB G’ Total MI (%)
H1 Control (distilled water), assessed after 48 h 08 01 04 02 00 01 16 2.8
H2 Extract 0.05 mL mL-1 added 24 h before assessment 05 02 00 01 01 02 11 1.2#
H3 Extract 0.05 mL mL-1 added 48 h before assessment 08 00 01 02 05 04 20 1.1#
H4 Extract 0.01 mL mL-1 added 48 h before assessment 16 00 01 00 00 00 17 1.9#
H5 Extract 0.1 mL mL-1 added 24 h before assessment 13 00 02 00 00 04 19 1.4#
H6 Bleomycin 10 μg mL-1 added 20 h before assessment 22 01 00 10 00 03 36 1.3#
H7 Extract 0.1 mL mL-1 added 48 h before assessment plus
bleomycin 10 μg mL-1 added 20 h before assessment
17 01 01 02 00 03 24† 1.0#
H8 Cyclophosphamide 6 μg mL mL-1 added 24 h before assessment 25 00 00 01 07 00 33 1.4#
H9 Extract 0.1 mL mL-1 added 48 h before assessment plus
cyclophosphamide 6 μg mL-1added 24 h before assessment
05 01 01 00 03 01 11‡ 0.8#
†significant at p < 0.05 compared to group H6. ‡significant at p < 0.05 compared to group H8. #significant at p < 0.05 compared to group H1.
Figure 1 - Kinetics of the oxidation inhibition of 2-deoxyribose by hydro-
gen peroxide (H2O2). Changes in absorbance (λ = 532 nm) mean trapping
action of AEP on hydroxyl radicals. Absorbencies were read every 5 min
for 40 min.
2-DR, so it is reasonable to assume that the anticlastogenic
effect of the extract against bleomycin was due to its anti-
oxidant properties. This is supported by the fact that the
micronuclei induced by bleomycin are mainly due to the
generation of ROS, so compounds with antioxidative activ-
ities could presumably modulate bleomycin-induced geno-
toxicity (Povirk and Austin, 1991; Povirk, 1996).
Cyclophosphamide clearly induced a dose-related
bone marrow micronucleus response in mouse polychro-
matic erythrocytes and bone marrow toxicity and the in
vivo treatment with 66 mg kg-1 bw cyclophosphamide, ei-
ther alone or in combination with the equivalent of
1 mL kg-1 bw of the extract, was toxic, as shown by the de-
creased proliferation index (Table 1). In genotoxicity eval-
uations as well as antimutagenic and/or anticlastogenic
studies of chemicals, the treatments should not be carried
out at levels that are toxic to the cells or animals, to avoid
cell-cycle inhibition. However, if no suitable data are avail-
able, a range finding is performed because dose levels
should cover a range from the maximum to little or not tox-
icity (US-EPA, 1998). Since cyclophosphamide is an alky-
lating agent that is metabolized to phospharamide mustard
which damages DNA by forming labile covalent DNA ad-
ducts and cross-links while bleomycin produces hydroxy
radicals the fact that in this study the extract was a more ef-
ficient anticlastogen against bleomycin than cyclophos-
phamide supports the hypothesis that antioxidants in the
extract inhibited chemical mutagenesis in vivo. These re-
sults are in agreement with many other studies showing that
ingredients present in plant extracts have antioxidant prop-
erties which can protect DNA against damage caused by
free radicals (Owen et al., 2003; Cano et al., 2003; Lee et
al., 2003). In the CHO-k1 cell experiments the reduced mi-
totic index indicated that bleomycin, cyclophosphamide
and extract induced a substantial delay in the cell-cycle,
while the pretreatment of cells with extract before the addi-
tion of bleomycin or cyclophosphamide depressed the
mitotic index even further. This interference with the cell-
cycle would be expected to result in a lower yield of
chromosome aberrations. The indirectly-acting mutagen
cyclophosphamide must be metabolically transformed to
interact with DNA but in our system the CHO-k1 cells were
sensitive to cyclophosphamide even without the S-9 mix
activation system. This data supports the observations of
some workers who unexpectedly reported that cyclophos-
phamide exhibited in vitro clastogenic activity in cultured
rat, rabbit and human lymphocytes without exogenous met-
abolic activation (Ikeuchi and Sasaki,1981; Abe et al. ,
1983; Dearfiled et al., 1983), raising the question of
whether or not the observed clastogenic effects were due to
the spontaneous hydrolysis of cyclophosphamide known to
occur at temperatures above 30 °C (Mohn and Ellenberger,
1976; Anderson 1995). In our study, in vitro
anticlastogenicity was observed in conjunction with spe-
cific cytotoxicity as shown by the significant reduction in
the mitotic index as compared to the H1 untreated control
(Table 2). However, our in vivo study indicated more
clearly that the extract had a protective effect against
bleomycin-induced oxidative damage. According to Liu et
al. (2003) and Berger (2005), an antioxidant dietary supple-
ment can reduce the level of DNA oxidative damage and
protect normal cells against the adverse side-effects of
some cancer chemotherapy protocols.
The 2-deoxyribose degradation assay supports the
data (Figure 1) on the in vivo and in vitro antioxidant effect
of the extract and its ability to scavenge hydroxyl radicals.
The fact that the extract was able to reduce Fe(III) to Fe(II)
suggests that redox cycling of Fe(III) formed by the Fenton
reaction could have occurred and that the extract was able
to prevent the generation of the hydroxy radicals and 2-deo-
xyribose oxidative damage induced by Fenton reagents.
The kinetics of the inhibition of 2-deoxyribose oxidation by
H2O2 are shown in Figure 1, which shows the decrease in
absorbance and hence the mean trapping action of the ex-
tract on hydroxyl radicals. This mechanism has been used
for the quantification of antioxidant properties of many
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Table 3 - Main antioxidant compounds, minerals and vitamins present in Caryocar brasiliense (pequi) pulp.
Fatty acids
(grams per 100g pulp)
Minerals
(mg 100 g -1 pulp)
Vitamins*
(mg per 100g of pulp)
Carotenoids
(unquantified)
Oleic acid 53.9 Fe 800 Vitamin C 12 β-carotene
Palmitic acid 40.2 Ca 50 Riboflavin 0.46 β-cryptoxanthin
Stearic acid 2.3 Na 2.1 Niacin 0.39 Lutein
Linoleic acid 1.5 Mn 0.6 Thiamin 0.03 Neoxanthin
Palmitoleic acid 1.4 Zn 0.5 Vitamin A 20000 U* Violaxanthin
Linolenic acid 0.7 Cu 0.4 Zeaxanthin
Araquidic acid 0.2 K 0.02
P 0.006
Mg 0.005
*Except for vitamin A, which is in units per 100 g. Source: fatty acids from Facioli and Gonçalves (1998); minerals, vitamins and carotenoids from
Azevedo-Meleiro and Rodrigues-Amaya (2004).
compounds present in fruits and vegetables (Lopes, 1999).
Our observations on the antioxidant activity of C.
brasiliense aqueous extract may in part explain the anti-
clastogenic potential of this compound.
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